Facebook
Twitter
Telegram
Fehler meldenFennec Pharmaceuticals Finanzdaten 2011-2024 | FENC
Jahresabschluß Fennec Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
296 M | 197 M | 145 M | 171 M | 127 M | 124 M | 135 M | 25.6 M | 22.3 M | 21.5 M | - | - | - |
Anteile |
26.6 M | 26.3 M | 26 M | 23.7 M | 20 M | 19 M | 15 M | 12.8 M | 10.8 M | 9.87 M | - | - | - |
Kurshistorie |
11.1 | 7.51 | 5.59 | 7.32 | 6.85 | 6.65 | 9.23 | - | - | - | - | - | - |
Nettogewinn |
-16 M | -23.7 M | -17.3 M | -18.1 M | -12.8 M | -9.89 M | -7.05 M | -2.79 M | -659 K | -2.18 M | 1.84 M | -5.16 M | 4.68 M |
Umsatz |
21.3 M | 1.54 M | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
1.26 M | 86 K | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
20 M | 1.45 M | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-12.8 M | -22.6 M | -17.2 M | -17.9 M | -13 M | -10.4 M | -6.95 M | -2.87 M | -1.89 M | -2.88 M | -1.93 M | -3.62 M | -3.44 M |
Zinsaufwendungen |
441 K | 195 K | - | -9 K | -17 K | 6 K | -8 K | -14 K | -9 K | - | - | - | - |
EBITDA |
-12.8 M | -22.6 M | -17.2 M | -17.5 M | -13 M | -10.6 M | -6.82 M | -2.96 M | -3.12 M | -3.58 M | -1.93 M | -3.6 M | -3.4 M |
Betriebsaufwand |
32.8 M | 24 M | 17.2 M | 18.1 M | 13 M | 10.4 M | 6.95 M | 2.87 M | 1.89 M | 2.88 M | 1.93 M | 3.62 M | 3.44 M |
Allgemeine und Verwaltungsausgaben |
20.6 M | 17.7 M | 12.2 M | 13 M | 7.4 M | 5.4 M | 5.02 M | 2.4 M | 1.63 M | 2.52 M | 1.33 M | 1.54 M | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Fennec Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
27 M | 27 M | 26.6 M | 26.5 M | 26.6 M | 26.4 M | 26.1 M | 26.1 M | 26 M | 26 M | 26 M | 26 M | 26 M | 26 M | 25.6 M | 23.4 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 19 M | 18.6 M | 18.4 M | 18.4 M | 15.7 M | 14.2 M | 13.6 M | 13.6 M | 13.6 M | 12.8 M | 10.9 M | 10.9 M | 10.9 M | 10.8 M | 10.6 M | 10.6 M | 9.86 M | 9.85 M | 9.77 M | 9.72 M | 8.39 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 25.2 K | 25.2 K | 25.2 K | 18.1 M | 25.2 M | 20.6 M |
Nettogewinn |
12.8 M | - | -1.87 M | -5.44 M | -6.05 M | - | -8.09 M | -5.07 M | -3.7 M | - | -4.18 M | -4 M | -4.73 M | - | -6.2 M | -4.84 M | -3.83 M | - | -1.81 M | -4.73 M | -2.63 M | - | -2.75 M | -2.59 M | -1.57 M | - | -2.35 M | -1.6 M | -806 K | -1.14 M | -502 K | -724 K | -502 K | -540 K | -123 K | -540 K | -540 K | - | -2.18 M | -2.18 M | -2.18 M | - | 1.84 M | 1.84 M | 1.84 M | - | -5.16 M | -5.16 M | -5.16 M | - | 4.68 M | 4.68 M | 4.68 M |
Umsatz |
25.4 M | - | 6.52 M | - | 1.68 M | - | - | - | - | - | - | - | - | - | 200 M | 200 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | 331 K | 148 K | 95 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | 6.18 M | 3.18 M | 1.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
13.7 M | - | -1.02 M | -4.67 M | -5.27 M | - | -7.9 M | -5.01 M | -3.55 M | - | -4.17 M | -3.92 M | -4.92 M | - | -5.86 M | -4.84 M | -3.84 M | - | -1.86 M | -4.81 M | -2.68 M | - | -2.85 M | -2.66 M | -1.79 M | - | -2.19 M | -1.48 M | -771 K | - | -564 K | -707 K | -454 K | - | -338 K | -549 K | -452 K | - | -619 K | -930 K | -537 K | - | -51 K | -927 K | -537 K | - | -630 K | -1.25 M | -616 K | - | -944 K | -572 K | -1.02 M |
Zinsaufwendungen |
197 K | - | 102 K | - | 109 K | - | 24 K | - | - | - | -1 K | 9 K | -8 K | - | -8 K | 13 K | -9 K | - | 1 K | -10 K | - | - | -2 K | 5 K | -3 K | - | 1 K | -4 K | -1 K | - | - | -3 K | -9 K | - | -2 K | -10 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | -7.9 M | -5.01 M | -3.55 M | - | -4.17 M | -3.92 M | -4.92 M | - | -5.86 M | -4.84 M | -3.84 M | - | -1.86 M | -4.81 M | -2.68 M | - | -2.85 M | -2.66 M | -1.79 M | - | -2.19 M | -1.48 M | -771 K | - | -564 K | -707 K | -454 K | - | -338 K | -549 K | -452 K | - | -619 K | -930 K | -537 K | - | -51 K | -927 K | -537 K | - | -630 K | -1.25 M | -616 K | - | -944 K | -572 K | -1.02 M |
Betriebsaufwand |
11.6 M | - | 7.2 M | -7.84 M | 6.95 M | - | 7.9 M | -5.01 M | 3.55 M | - | - | - | 4.92 M | - | - | - | 3.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 51 K | 927 K | - | - | 630 K | 1.25 M | - | - | 944 K | 572 K | - |
Allgemeine und Verwaltungsausgaben |
5.87 M | - | 3.8 M | 5.5 M | 4.32 M | - | 7.05 M | 3.88 M | 2.11 M | - | 2.93 M | 3.12 M | 2.51 M | - | 4.49 M | 3.72 M | 2.44 M | - | 1.07 M | 2.84 M | 1.01 M | - | 1.05 M | 1.87 M | 1.1 M | - | 1.69 M | 1.15 M | 546 K | - | 452 K | 568 K | 407 K | - | 250 K | 495 K | 409 K | - | 531 K | 858 K | 505 K | - | 275 K | 373 K | 359 K | - | 273 K | 390 K | 320 K | - | 505 K | 338 K | 706 K |
Alle Zahlen in USD-Währung